PainCeptor Pharma names new senior development exec

Montreal, QC – PainCeptor Pharma, a biotech company specializing in the development of therapeutic compounds for the treatment of acute and chronic pain, has named Dr Francine Gervais to the position of senior vice-president and vice-president of pharmaceutical development.<br>
<br>
“Dr Gervais’ renowned academic background and unique experience in the development of new medicines will be instrumental in the future growth of our company and success of our innovative products,” says Dr Louis Lamontagne, the company’s president and CEO. <br>
<br>
In her new position, she will be responsible for the pharmaceutical development of preliminary lead drug candidates emerging from PainCeptor’s laboratories. <br>
<br>
She was previously vice-president of research and development at Neurochem.<br>